Last reviewed · How we verify
NCT07184814: CAPTAIN
Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement
trial in Takayasu Arteritis With Pulmonary Artery Involvement in 150 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | China-Japan Friendship Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 January 2016 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Conditions studied
- Takayasu Arteritis With Pulmonary Artery Involvement — all drugs for Takayasu Arteritis With Pulmonary Artery Involvement →
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease — all drugs for Pulmonary Arterial Hypertension Associated With Connective Tissue Disease →
Sponsor
China-Japan Friendship Hospital
Who can join
18 and older, any sex, with Takayasu Arteritis With Pulmonary Artery Involvement or Pulmonary Arterial Hypertension Associated With Connective Tissue Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pulmonary hypertension in Takayasu arteritis with pulmonary artery involvement: risk factors and impact on mortality.
Zheng S, Li Y, Liu Z, Chen Y, et al · · 2026 · PMID 41922023 · DOI 10.1136/bmjresp-2025-003854
Verify or expand the search:
- PubMed search for NCT07184814
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Takayasu Arteritis With Pulmonary Artery Involvement
Currently open trials in the same condition.
- NCT05388682 — Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement · recruiting
Other China-Japan Friendship Hospital trials
Trials by the same sponsor.
- NCT07482995 — Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults · NA · not yet recruiting
- NCT07406932 — A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial L · NA · not yet recruiting
- NCT07509775 — Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on · recruiting
- NCT07339956 — Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents · EARLY_PHASE1 · not yet recruiting
- NCT07280429 — ICIAM Rehabilitation Program Study: A Randomized Controlled Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07184814 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China-Japan Friendship Hospital
- Last refreshed: 22 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07184814.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing